Coinfection, coepidemics of COVID‐19, and dengue in dengue‐endemic countries: A serious health concern

Miah, Mohammad Asaduzzaman; Husna, Asmaul

doi:10.1002/jmv.26269

Cited by 50 publications

(58 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Two clear cases of co-infection have been reported previously in Reunion Island ( Verduyn et al, 2020 ) and in Mayotte of French ( Epelboin et al, 2020 ). Nevertheless possible co-infection also have been noticed in Asia ( Miah and Husna, 2020 ). A study in Bangladesh found that co-infection occurred among 25% out of 20 patients and co-infection was associated with high mortality rate ( Saddique et al, 2020 ) alarming the dengue-endemic countries in the region.…”

Section: Discussionmentioning

confidence: 99%

Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from Indonesia

Masyeni

Santoso

Widyaningsih

et al. 2021

International Journal of Infectious Diseases

125

104

View full text Add to dashboard Cite

Highlights We reported dengue and COVID-19 co-infection for the first time in Indonesia. We revealed possible cross-reactivity between SARS-CoV-2 and DENV antibodies based on rapid serological tests. Cross-reactivity of SARS-CoV-2 and DENV will be a significant hurdle to have a simple point-of-care test for COVID-19 in dengue-endemic countries.

show abstract

Section: Discussionmentioning

confidence: 99%

Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from Indonesia

Masyeni

Santoso

Widyaningsih

et al. 2021

International Journal of Infectious Diseases

125

104

View full text Add to dashboard Cite

show abstract

“…Co-infection with tuberculosis or dengue for example may result in delayed diagnosis and treatment and can further spread infection. 5 Close collaboration with infection control and infectious disease specialists can help minimize these risks.…”

Section: Strategy 2: Identify and Treat Co-infectionsmentioning

confidence: 99%

<p>Optimizing Supportive Care in COVID-19 Patients: A Multidisciplinary Approach</p>

Haleeqa¹,

Alshamsi²,

Habib³

et al. 2020

JMDH

View full text Add to dashboard Cite

Within just a few months, SARS-CoV-2 has evolved from a virtually unknown pathogen to a leading cause of morbidity and mortality worldwide. As COVID-19 infection can affect multiple organ systems, treating many manifestations and complications requires clinical expertise across the healthcare professional spectrum. Therefore, interprofessional and multidisciplinary collaboration should form the cornerstone of every hospital's COVID-19 management approach. In this manuscript, we discuss the non-microbial management strategies for our COVID-19 inpatient population. Specifically, through an inter-professional and collaborative approach to care delivery, we provide rationale and guidance on prone positioning, oxygen strategies, early mobilization, identifying and treating co-infections, anticoagulation and ensuring appropriate psychological support for patients and their families. It is our hope that these recommendations help supporting clinician management decisions to best care for hospitalized COVID-19 patients in the region and worldwide.

show abstract

“…A number of countries with particularly severe COVID-19 epidemics regularly experience dengue epidemics (e.g., Peru, Brazil, and Indonesia), and there have been reports of 2020 being an above-average year for dengue in South America (7). A number of warnings have been raised regarding the potential dangers of overlapping dengue and COVID-19 epidemics; e.g., both diseases can result in similar symptoms and there have been reports of serological cross-reaction, which increases the chance of misdiagnosis (8)(9)(10)(11)(12)(13)(14). At least five cases of dengue-COVID-19 co-infection have been reported, one of which resulted in death by stroke (9,(14)(15)(16)(17)(18).…”

Section: Introductionmentioning

confidence: 99%

The impacts of COVID-19 mitigation on dengue virus transmission: a modelling study

España

et al. 2020

Preprint

View full text Add to dashboard Cite

SummaryBackgroundThe COVID-19 pandemic has induced unprecedented reductions in human mobility and social contacts throughout the world. Because dengue virus (DENV) transmission is strongly driven by human mobility, behavioral changes associated with the pandemic have been hypothesized to impact dengue incidence. By discouraging human contact, COVID-19 control measures have also disrupted dengue vector control interventions, the most effective of which require entry into homes.MethodWe used an agent-based model with a realistic treatment of human mobility and vector control to investigate how and why dengue incidence could differ under a lockdown scenario with a proportion of the population sheltered at home.ResultWe found that a lockdown in which 70% of the population sheltered at home led to a small average increase in cumulative DENV infections of up to 10%, depending on the time of year lockdown occurred. Lockdown had a more pronounced effect on the spatial distribution of DENV infections, with higher incidence under lockdown in regions with high mosquito abundance. Transmission was also more focused in homes following lockdown. The proportion of people infected in their own home rose from 54% under normal conditions to 66% under lockdown, and the household secondary attack rate rose from 0.109 to 0.128, a 17% increase. When we considered that lockdown measures could disrupt regular, city-wide vector control campaigns, the increase in incidence was more pronounced than with lockdown alone, especially if lockdown occurred at the optimal time for vector control.DiscussionOur results indicate that an unintended outcome of COVID-19 control measures may be to adversely alter the epidemiology of dengue. This observation has important implications for an improved understanding of dengue epidemiology and effective application of dengue vector control. When coordinating public health responses during a syndemic, it is important to monitor multiple infections and understand that an intervention against one disease may exacerbate another.

show abstract

Coinfection, coepidemics of COVID‐19, and dengue in dengue‐endemic countries: A serious health concern

Cited by 50 publications

References 4 publications

Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from Indonesia

Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from Indonesia

<p>Optimizing Supportive Care in COVID-19 Patients: A Multidisciplinary Approach</p>

The impacts of COVID-19 mitigation on dengue virus transmission: a modelling study

Contact Info

Product

Resources

About